Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey.
Maurer M, Caballero T, Aberer W, Zanichelli A, Bouillet L, Bygum A, Grumach AS, Botha J, Andresen I, Longhurst HJ; IOS Study Group. Maurer M, et al. Among authors: andresen i. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):2421-2430. doi: 10.1111/jdv.17654. Epub 2021 Oct 5. J Eur Acad Dermatol Venereol. 2021. PMID: 34506666
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.
Aberer W, Maurer M, Bouillet L, Zanichelli A, Caballero T, Longhurst HJ, Perrin A, Andresen I; IOS Study Group. Aberer W, et al. Among authors: andresen i. Allergy Asthma Clin Immunol. 2017 Jul 5;13:31. doi: 10.1186/s13223-017-0203-z. eCollection 2017. Allergy Asthma Clin Immunol. 2017. PMID: 28690642 Free PMC article.
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.
Caballero T, Zanichelli A, Aberer W, Maurer M, Longhurst HJ, Bouillet L, Andresen I; IOS Study Group. Caballero T, et al. Among authors: andresen i. Clin Transl Allergy. 2018 Mar 23;8:11. doi: 10.1186/s13601-018-0195-x. eCollection 2018. Clin Transl Allergy. 2018. PMID: 29599966 Free PMC article.
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.
Grumach AS, Longhurst HJ, Aberer W, Bouillet L, Caballero T, Bygum A, Zanichelli A, Botha J, Andresen I, Maurer M; Icatibant Outcome Survey investigators. Grumach AS, et al. Among authors: andresen i. J Allergy Clin Immunol Pract. 2019 Mar;7(3):1078-1080. doi: 10.1016/j.jaip.2018.07.047. Epub 2018 Aug 28. J Allergy Clin Immunol Pract. 2019. PMID: 30170163 Free article. No abstract available.
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey.
Zanichelli A, Magerl M, Longhurst HJ, Aberer W, Caballero T, Bouillet L, Bygum A, Grumach AS, Botha J, Andresen I, Maurer M; IOS Study Group. Zanichelli A, et al. Among authors: andresen i. Clin Transl Allergy. 2018 Oct 12;8:42. doi: 10.1186/s13601-018-0229-4. eCollection 2018. Clin Transl Allergy. 2018. PMID: 30338053 Free PMC article.
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.
Bygum A, Caballero T, Grumach AS, Longhurst HJ, Bouillet L, Aberer W, Zanichelli A, Botha J, Andresen I, Maurer M; IOS Study Group. Bygum A, et al. Among authors: andresen i. Clin Transl Allergy. 2019 Jul 19;9:37. doi: 10.1186/s13601-019-0272-9. eCollection 2019. Clin Transl Allergy. 2019. PMID: 31360439 Free PMC article.
53 results